Lacidofil®: The Original Formula for A Resilient Gut Microbiome

CASE STUDY
Submission from Lallemand

It all starts in the gut with our proprietary probiotic solutions! With over 160 publications (including preclinical and clinical studies) Lallemand Health Solutions’ thoroughly documented bacteria and yeast strains provide beneficial health effects such as on gut microbiota balance and or incidence of diarrhea and constipation. They also support the intestinal flora of specific populations, such as infants during their first year of life and adults with certain gut health conditions.
The innovation.
Lacidofil®: Recent Study Reveals Promising Results for H. pylori Eradication
Among our most documented solutions is the probiotic formula, Lacidofil®, which combines two proprietary bacterial strains: L. rhamnosus Rosell®-11 and L. helveticus Rosell®-52. Supported by over 29 clinical trials, Lacidofil® has consistently shown its beneficial effects on maintaining healthy intestinal microbiota, leading to overall well-being in humans. A recent study [Kiattiweerasak, 2023] strengthens existing evidence that Lacidofil® is an effective adjuvant to standard therapy for Helicobacter pylori (H. pylori) eradication and reduces the side effects of antibiotics used in this therapy.
The benefits.
Lacidofil® decreases gastrointestinal discomfort and improves general health-related quality of life
The results demonstrate the efficacy and safety of Lacidofil® in statistically significantly increasing gastrointestinal comfort whilst improving general health-related quality of life at week six compared to the placebo group. The study also highlights that Lacidofil® can significantly increase the eradication rate of H. pylori.
Lacidofil® is available in over 20 countries, both as a standalone product and as an ingredient in combination with other strains. With a proven record of safe use and a robust pharmacovigilance program, Lacidofil® has earned Canadian approval for various health claims. These include promoting healthy microflora in infants as young as two months old, addressing Antibiotic-Associated Diarrhea (AAD), management of acute diarrhea, support of gastrointestinal balance during H. pylori eradication therapy, as well as offering non- specific general well-being benefits to pregnant women.
Lacidofil® is available in various forms, including powders, capsules, and drops, a versatility that meets current market probiotic solution demand.
Additional materials:
Visit our dedicated website to learn more



